NL-OMON21625
Completed
Not Applicable
A randomised, controlled, double-blind trial to evaluate intestinal tolerance of a renewed anti-reflux formula in infants with regurgitation.
Danone Research – Centre for Specialised Nutrition0 sites98 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Danone Research – Centre for Specialised Nutrition
- Enrollment
- 98
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Healthy term infants (37\-42 weeks gestation at birth);
- •2\. Age \<\= 3 months at screening;
Exclusion Criteria
- •1\. Clinically significant congenital disease including gastroesophageal, respiratory, and neurological disorders, (suspicion of) food allergies, and disease affecting normal growth;
- •2\. Gastrointestinal infection within 4 weeks prior to randomisation;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Randomised, double-blind, controlled, multi-country and multi-centre intervention study.- Healthy toddlers, 18 - 36 month old- growing up milk- Vitamin D level- Iron levelNL-OMON29128Danone Research – Centre for Specialised Nutrition288
Not yet recruiting
Not Applicable
Study to explore the effect of a Growing Up Milk with added synbiotics on the intestinal microbiota of healthy Asian toddlers.Healthy toddlersNL-OMON21383Danone Research ¨C Centre for Specialised Nutrition130
Completed
Not Applicable
An Amino Acid based Formula with synbiotics: Effects on gut microbiota diversity and clinical effectiveness in suspected gastrointestinal non-IgE mediated Cow’s Milk Allergy (ASSIGN I).Cow's milk allergyNL-OMON20641Danone Research – Centre for Specialised Nutrition68
Not yet recruiting
Not Applicable
A study on the effect of a Growing up milk on the occurrence of infections in toddlersNL-OMON27240Danone Research B.V. (formerly known as Numico Research B.V.)650
Completed
Not Applicable
Randomized, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischemia.Refractory angina pectoris and documented myocardial ischemia.NL-OMON29227Departmartement of Cardiology,Leiden University Medical Center ,Leiden, the Netherlands50